NDC 49702-231 – Triumeq
Abacavir Sulfate 600 mg/1; Dolutegravir Sodium 50 mg/1; Lamivudine 300 mg/1 · Tablet, Film Coated · Oral
Product NDC49702-231
Product details
- Brand name
- Triumeq
- Generic name
- abacavir sulfate, dolutegravir sodium, lamivudine
- Labeler
- ViiV Healthcare Company
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA205551
- Marketed since
- August 22, 2014
- Listing expires
- December 31, 2027
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Abacavir Sulfate 600 mg/1
- Dolutegravir Sodium 50 mg/1
- Lamivudine 300 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 49702-231-13 | 30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13) | Aug 22, 2014 |
Recalls mentioning this NDC
- D-0486-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.